Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED) - Trial NCT05574868
Access comprehensive clinical trial information for NCT05574868 through Pure Global AI's free database. This phase not specified trial is sponsored by Rigicon, Inc. and is currently Recruiting. The study focuses on Erectile Dysfunction. Target enrollment is 177 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Rigicon, Inc.
Timeline & Enrollment
N/A
Jul 11, 2022
May 21, 2026
Primary Outcome
Rigidity at 12 months,Survival at 12 months
Summary
This study evaluates the long-term safety and efficacy of the use of the Rigicon Infla 10®
 Three-Piece Inflatable Penile Prosthesis in patients with erectile dysfunction. This study
 follows patients implanted with the Rigicon Infla 10® Three-Piece Inflatable Penile
 Prosthesis for up to 3 years after implantation.
 
 This study will take approximately 6 months to enroll all subjects. (14 days, 1 month, 6
 months, 12 months,18 months, 24 months, and 36 months, post-procedure. )
 
 Subjects will be followed per protocol and institutional standard of care for ED and
 comorbidities.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05574868
Device Trial